- Telehealth Visits
- Insurance plan information
Jocelyn Chapman, MD
Gynecologic Oncology • Gynecologic Surgical OncologyCo-director, Multidisciplinary Approach to the Placenta Service- Telehealth Visits
- Insurance plan information
Jocelyn Chapman, MD
Gynecologic Oncology • Gynecologic Surgical OncologyCo-director, Multidisciplinary Approach to the Placenta Service- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Jocelyn Chapman specializes in the surgical and medical treatment of gynecologic malignancies. She cares for patients with both cancerous and complex noncancerous diseases of the female reproductive system. In addition to expertise in the aggressive surgical management of advanced ovarian and uterine cancers, she has special training in minimally invasive procedures (laparoscopic and robotic surgery), benefiting appropriately selected patients.
Chapman's clinical research focuses on enhancing surgical and preoperative processes to ensure that all gynecologic cancer patients at UCSF receive safe, superior care. With her expertise in computational genomics, she also collaborates with UCSF cancer researchers to better understand the genetic vulnerabilities in gynecologic cancer and to use them for targeted therapies. Her research has been published in Gynecologic Oncology, Journal of the National Comprehensive Cancer Network and Nature Biotechnology.
Chapman earned her medical degree from Boston University School of Medicine. She completed her residency at UCSF and received specialty training through the joint Stanford-UCSF gynecologic oncology fellowship.
Education & training
Board certification
- Gynecologic Oncology, American Board of Obstetrics and Gynecology
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
Fellowship
- Gynecologic Oncology, Stanford University School of Medicine
Residency
- Obstetrics & Gynecology, UCSF School of Medicine -GME
Degree
- MD, Boston University School of Medicine
Academic title
- Clinical Professor
My expertise
Locations
My research
Clinical trials
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal CancerOpens in a new window
Recruiting
To assess percentage of patients with advanced-stage ovarian, fallopian tube, and peritoneal cancers per Response Evaluation Criteria in Solid Tumors (RECIST)1...A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerOpens in a new window
Recruiting
Progression-free survival (PFS) according to RECIST version 1.1, per blinded independent central review (BICR)
Publications
Showing 1-6 of 74 reviews
- May 27, 20265 out of 5 Stars
Dr. Chapman is an amazing physician! Communication was super, she answered all questions and gave superb care.
- May 19, 20265 out of 5 Stars
Everyone has been incredibly caring, professional and I've felt I've had excellent care. I'm very grateful.
- May 15, 20265 out of 5 Stars
I always enjoy seeing Dr. Chapman
- May 13, 20265 out of 5 Stars
Dr. Chapman is excellent. I trust her 100%. Thank you Dr. Chapman!
- May 7, 20265 out of 5 Stars
I can't say enough good things about her Dr. Rami. They are wonderful. I'm so lucky to be Dr. Chapman's patient.
- April 21, 20265 out of 5 Stars
Dr. Chapman had taken excellent care of me throughout this process. I'm very grateful for her skill, support, and guidance.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.